H. Lee Moffitt Cancer Center and Research Institute clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-17 | NCT07940738 Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution… | Phase 1 | Recruiting |
| 2026-11-16 | NCT07937423 DYNAMIC Pilot Optimization Trial | Not Yet Recruiting | |
| 2026-11-10 | NCT07930182 Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring | Phase 2 | Recruiting |
Active trials by phase
| Early Phase 1 | 7 | |
| Phase 1 | 25 | |
| Phase 1/2 | 9 | |
| Phase 2 | 55 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
Not charted: 41 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 33
Breast Cancer (18) · Melanoma (14) · Leukemia (12) · Lung Cancer (10) · Prostate Cancer (10) · Pancreatic Cancer (9) · Colorectal Cancer (7) · Non-Hodgkin Lymphoma (7) · Non-Small Cell Lung Cancer (NSCLC) (7) · Acute Myeloid Leukemia (AML) (6)
Get alerts when H. Lee Moffitt Cancer Center and Research Institute's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.